ArticleCNS oncology2016

Widely metastatic atypical pituitary adenoma with mTOR pathway STK11(F298L) mutation treated with everolimus therapy.

Laura E Donovan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.